宇邦新材 reported revenue of ¥1.68B for the period ended 2026-06-30, +10.4% year on year. Net income was ¥0.07B, a 4.1% net margin on a 10.1% gross margin. The largest revenue line is 互连焊带 at 80% of the total. Free cash flow for the period was ¥-0.14B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.68B | +10.4% |
| Gross profit | ¥0.17B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.07B | +88.4% |
| Gross margin | 10.1% | Net margin 4.1% |
| Revenue Q/Q | -8.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 互连焊带 | ¥1.35B | 80.5% |
| 汇流焊带 | ¥0.28B | 16.8% |
| 其他主营业务 | ¥0.04B | 2.3% |
| 光伏发电 | ¥0.01B | 0.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.51B | 89.9% |
| R&D | ¥0.03B | 1.9% |
| SG&A | ¥0.02B | 1.0% |
| Tax & other | ¥0.00B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥3.30B |
| Total liabilities | ¥1.42B |
| Shareholders' equity | ¥1.88B |
| Equity / assets | 57.0% |
| Operating cash flow | ¥-0.14B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.14B |
| Cash conversion (OCF / net income) | -289% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华厦眼科 ・ 铭利达 ・ 汉仪股份 ・ 英华特 ・ 瑞晨环保 ・ 汉朔科技 ・ 嘉曼服饰 ・ 新天地 ・ 快可电子 ・ 金道科技 ・ 珠城科技 ・ 科源制药
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies